HOME  | CONTACT  | PATIENT LOGIN  | CLINIC LOGIN  | FAQ
  • PATIENTS &
    HEALTHY VOLUNTEERS
  • INVESTIGATORS
  • CROS / SPONSORS
  • CAREERS
  • TRIAL ALERTS

TRIALS SEARCH
      
  • HEALTH NEWS

  • RSS FEEDS

  • ABOUT TRIALS

  • LINK TO US


View Clinical Trial (Medical Research Study)


Prospective SecurAcath Subcutaneous Securement Clinical Trial

Signup
Browse Studies

City:   St. Paul
State:   Minnesota
Zip Code:   55102
Conditions:   Peripherally Inserted Central Catheter
Purpose:   To prospectively monitor the safety and performance of the catheter securement device in subjects whose catheter is secured with the Interrad Medical SecureAcath device.
Study Summary:   Peripherally inserted central catheters (PICCs) and Central Venous Catheter (CVC) are widely used to deliver fluids directly to the central venous system and can remain in place for as short as a few days to as long as months. One of the highest risks in the use of these catheters is infection, both local and systemic. Currently, these catheters are secured by either sutures or adhesive patches. Sutures can create additional potential entry points for bacteria whereas both sutures and adhesive securement patches hold the catheter hub to the skin resulting in increased difficulty cleaning around the catheter entry site. Furthermore, securing a catheter outside the skin away from the catheter entry point, as with sutures or adhesive securement patches may potentiate pistoning of the catheter which is also believed to possibly increase infection risks. A second risk of intravenous catheter use is dislodgement during normal use and site maintenance. These catheters are often manipulated multiple times a day for blood sampling or injection of fluids. During manipulation, the catheter can be dislodged thus requiring an unplanned replacement of the catheter. Interrad Medical has developed a means to secure indwelling catheters using a small subcutaneous anchor. With this system, cleaning around the catheter entry site is made easier and can be more thorough. The system is also designed to minimize the risk of catheter dislodgement because once the anchor is deployed, the catheter remains secured. This may simplify dressing changes compared to adhesive devices such as Statlock, which requires the catheter be released from the device and therefore be unsecured during dressing changes. The objective of this post-market study is to monitor the safety and performance of the SecurAcath when used to secure the catheter to the insertion site via a subcutaneous anchor. The data collected may provide insight for future enhancements to improve the safety and utility of the device. It also provides a means for an early warning of any identified safety issues, and allows physicians to share their experiences thereby improve the quality of care provided to the patients.
Criteria:   Inclusion Criteria: - Age 18 or older - Requires an intravenous catheter to be placed Exclusion Criteria: - Inability to understand the study or a history of non-compliance with medical advice. - Unwilling or unable to sign Informed Consent Form (ICF). - Had a previous catheter placed in the same side within the last 3 months. - Known central venous thrombosis or occlusion or stenosis on the side of the body to be used for the catheter. - History of upper extremity venous thrombosis on the side of the body to be used for the catheter. - Known hypercoagulable disorder. - Diffuse skin inflammatory condition or rashes on the side to be used for the catheter line. - Peripheral chemotherapy therapy in the same side as that to be used for the catheter line within 3 months. - Known hypersensitivity to nickel. - Any infection associated with positive blood cultures that are still present after 48 hours of antibiotic therapy. - Previous mastectomy or axillary lymph node dissection on the same side as catheter implant. - Subjects on chronic or recurrent systemic steroid medications for 6 months or longer.
NCT ID:   NCT00903539
Primary Contact:   Robin Euphosin
Phone: 763-477-5606
Email: reuphosin@libramed.com
Backup Contact:   N/A
Location Contact:   St. Paul, Minnesota 55102
United States

Kathleen Madden, CNP
Phone: 651-232-3183
Email: kmadden@stpaulrad.com

Site Status: Recruiting

Data Source:   ClinicalTrials.gov
Date Processed:   May 20, 2013
Modifications to this listing:   Only selected fields are shown, please use the link below to view all information about this clinical trial.
Click to view Full Listing


If you would like to be contacted by the clinical trial representative please enter your contact information, then click "I Am Interested In This Study"
First Name:  
Last Name:  
Email Address:  
Confirm Email:    
Daytime Phone (eg. 555-555-5555):  
City:  
State:
Zip Code:    
Best Time to Call:  
Questions/Comments:  
  • NEARBY STUDIES

Within 25 Miles

Dry Eye - Stillwater MN

Irritable Bowel Syndrome (with diarrhea) - Chaska MN

Multiple Sclerosis - Minneapolis MN

Obsessive Compulsive Disorder (OCD) - Minneapolis MN

Uncontrolled Angina (Adult Stem Cell Research) - Minneapolis MN

COPD (Emphysema and Chronic Bronchitis) - Minneapolis MN

COPD (Emphysema and Chronic Bronchitis) - Minneapolis MN

Within 50 Miles

Within 100 Miles

Multiple Myeloma, Mantle Cell Lymphoma, Diffuse Large B Cell Lymphoma - Rochester MN

Uncontrolled Angina (Adult Stem Cell Research) - Rochester MN

 
Clinical Connections Home | Investigators | CROs / Sponsors | Clinical Trials Notification | Search Clinical Trials | About Clinical Trials | Links | Terms And Conditions | Sitemap | Suggestions / Feedback
© 1998-2013 | All trademarks are property of their legal owners. | All Rights Reserved

ClinicalConnection.com is a resource that provides individuals with information regarding clinical trials that are being conducted worldwide.

ClinicalConnection.com does not conduct these clinical trials nor endorse them. Please consult your doctor or physician before participating.